
Bionano Genomics Investor Relations Material
Latest events

Q2 2025
Bionano Genomics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bionano Genomics Inc
Access all reports
Bionano Genomics provides genome analysis software solutions for structural variation discovery and genome assembly enhancement. The Company's Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the characterization of these targets. The company was founded in 2003 and is headquartered in San Diego, California.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
BNGO
Country
🇺🇸 United States